JP2013539966A5 - - Google Patents

Download PDF

Info

Publication number
JP2013539966A5
JP2013539966A5 JP2013527364A JP2013527364A JP2013539966A5 JP 2013539966 A5 JP2013539966 A5 JP 2013539966A5 JP 2013527364 A JP2013527364 A JP 2013527364A JP 2013527364 A JP2013527364 A JP 2013527364A JP 2013539966 A5 JP2013539966 A5 JP 2013539966A5
Authority
JP
Japan
Prior art keywords
item
cell population
tumorigenic cell
tumor
tumorigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013527364A
Other languages
English (en)
Japanese (ja)
Other versions
JP6240504B2 (ja
JP2013539966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/050451 external-priority patent/WO2012031280A2/en
Publication of JP2013539966A publication Critical patent/JP2013539966A/ja
Publication of JP2013539966A5 publication Critical patent/JP2013539966A5/ja
Application granted granted Critical
Publication of JP6240504B2 publication Critical patent/JP6240504B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013527364A 2010-09-03 2011-09-02 細胞亜集団の同定及び濃縮 Expired - Fee Related JP6240504B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38018110P 2010-09-03 2010-09-03
US61/380,181 2010-09-03
US201161510413P 2011-07-21 2011-07-21
US61/510,413 2011-07-21
PCT/US2011/050451 WO2012031280A2 (en) 2010-09-03 2011-09-02 Identification and enrichment of cell subpopulations

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2016040197A Division JP2016104037A (ja) 2010-09-03 2016-03-02 細胞亜集団の同定及び濃縮
JP2017158414A Division JP2018023387A (ja) 2010-09-03 2017-08-21 細胞亜集団の同定及び濃縮

Publications (3)

Publication Number Publication Date
JP2013539966A JP2013539966A (ja) 2013-10-31
JP2013539966A5 true JP2013539966A5 (https=) 2014-10-23
JP6240504B2 JP6240504B2 (ja) 2017-11-29

Family

ID=45048186

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013527364A Expired - Fee Related JP6240504B2 (ja) 2010-09-03 2011-09-02 細胞亜集団の同定及び濃縮
JP2016040197A Pending JP2016104037A (ja) 2010-09-03 2016-03-02 細胞亜集団の同定及び濃縮
JP2017158414A Withdrawn JP2018023387A (ja) 2010-09-03 2017-08-21 細胞亜集団の同定及び濃縮

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016040197A Pending JP2016104037A (ja) 2010-09-03 2016-03-02 細胞亜集団の同定及び濃縮
JP2017158414A Withdrawn JP2018023387A (ja) 2010-09-03 2017-08-21 細胞亜集団の同定及び濃縮

Country Status (8)

Country Link
US (1) US9945842B2 (https=)
EP (2) EP2689787A1 (https=)
JP (3) JP6240504B2 (https=)
CN (2) CN106434561A (https=)
AU (3) AU2011295722B2 (https=)
CA (1) CA2809864A1 (https=)
SG (2) SG189212A1 (https=)
WO (1) WO2012031280A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
AU2011295715B9 (en) * 2010-09-03 2017-02-23 Abbvie Stemcentrx Llc Novel modulators and methods of use
EP2689787A1 (en) 2010-09-03 2014-01-29 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
NZ611428A (en) 2010-12-08 2015-07-31 Stemcentrx Inc Novel modulators and methods of use
SA112330278B1 (ar) 2011-02-18 2015-10-09 ستيم سينتركس، انك. مواد ضابطة جديدة وطرق للاستخدام
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
DK2817620T3 (en) * 2012-02-22 2016-09-05 Verik Bio Inc IMMUNTERY TREATMENT SYSTEM FOR TUMOR FORMATION AND PROGRESSION
BR112014020826A8 (pt) 2012-02-24 2017-09-19 Stem Centrx Inc Anticorpo que se liga especificamente a um epítopo, ácido nucleico, vetor ou célula hospedeira, conjugado de fármaco – anticorpo, composição farmacêutica compreendendo o referido anticorpo, uso do mesmo, kit e método de preparação do conjugado
EP3539985A1 (en) 2012-02-24 2019-09-18 AbbVie Stemcentrx LLC Anti sez6 antibodies and methods of use
EP2864794A4 (en) * 2012-06-20 2016-03-02 Merrimack Pharmaceuticals Inc MARKER QUANTIFICATION IN INDIVIDUAL CELLS IN TISSUE CUTS
US10047163B2 (en) 2013-02-08 2018-08-14 Abbvie Stemcentrx Llc Multispecific constructs
ES2731681T3 (es) 2013-02-22 2019-11-18 Abbvie Stemcentrx Llc Conjugados de anticuerpo anti-DLL3 y PBD y usos de los mismos
HK1222871A1 (zh) * 2013-05-13 2017-07-14 Medimmune, Llc 具有最小单体分离的重组多克隆抗体多聚体的分离
SG11201601424PA (en) 2013-08-28 2016-03-30 Stemcentrx Inc Site-specific antibody conjugation methods and compositions
CN105792836A (zh) 2013-08-28 2016-07-20 施特姆森特克斯股份有限公司 新型sez6调节剂以及应用方法
JP2016540826A (ja) 2013-11-04 2016-12-28 ファイザー・インク 抗ｅｆｎａ４抗体−薬物コンジュゲート
RU2016122041A (ru) 2013-11-06 2017-12-11 ЭББВИ СТЕМСЕНТРКС ЭлЭлСи Новые анти-клаудин антитела и способы их применения
SG11201604664PA (en) 2013-12-12 2016-07-28 Stemcentrx Inc Novel anti-dpep3 antibodies and methods of use
US20150216908A1 (en) * 2014-02-06 2015-08-06 Steminent Biotherapeutics Inc. Quadri-positive stromal cell (qpsc) population for superior cell protection and immunomodulation
CA2939941A1 (en) 2014-02-21 2015-08-27 Abbvie Stemcentrx Llc Anti-dll3 antibodies and drug conjugates for use in melanoma
RU2708075C2 (ru) 2014-04-30 2019-12-04 Пфайзер Инк. Конъюгаты анти-ртк7 антитело-лекарственное средство
US10883994B2 (en) 2014-06-25 2021-01-05 Tel Hashomer Medical Research Infrastructure And Services Ltd. Identification of cancer stem cells markers and use of same for diagnosis and treatment
TW201617368A (zh) 2014-09-05 2016-05-16 史坦森特瑞斯公司 新穎抗ｍｆｉ２抗體及使用方法
EP3371594A1 (en) 2015-11-06 2018-09-12 Ventana Medical Systems, Inc. Representative diagnostics
CN107102141A (zh) * 2016-02-23 2017-08-29 中国科学院生物物理研究所 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用
JP2019522960A (ja) 2016-04-21 2019-08-22 アッヴィ・ステムセントルクス・エル・エル・シー 新規の抗ｂｍｐｒ１ｂ抗体及び使用方法
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN110093311B (zh) * 2018-01-29 2026-03-24 中国科学院上海营养与健康研究所 Icam-1标记及其应用
CN109270262B (zh) * 2018-10-08 2022-05-20 宁波美晶医疗技术有限公司 一种基于微流体技术的激光单细胞提取方法
CN110567788B (zh) * 2019-09-20 2022-02-11 北京蛋白质组研究中心 一种rna-蛋白质复合物的富集和鉴定方法
CN116732182A (zh) * 2023-07-19 2023-09-12 浙江大学 与肝癌相关的生物标志物及其应用

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444487A (en) 1979-07-02 1984-04-24 Xerox Corporation Multiple-flash fuser
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4703004A (en) 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US4745055A (en) 1985-05-07 1988-05-17 California Biotechnology Inc. Fused protein for enzyme immunoassay system
CA1340456C (en) 1986-07-07 1999-03-23 Hubert J.P. Schoemaker Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
GB8626412D0 (en) 1986-11-05 1986-12-03 Clark M R Antibodies
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
WO1991002002A1 (en) 1989-07-21 1991-02-21 Washington University Recombinantly produced human membrane cofactor protein (mcp)
US6117985A (en) 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
JP2001502537A (ja) 1996-10-15 2001-02-27 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア ヒト前立腺ガンの進行の動物モデル
US7361336B1 (en) 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
US6004528A (en) 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline
US8119101B2 (en) 1999-05-10 2012-02-21 The Ohio State University Anti-CD74 immunoconjugates and methods of use
US6642009B2 (en) 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
JP2001057828A (ja) 1999-08-20 2001-03-06 Toray Ind Inc 癌性疼痛モデル動物及びそれを用いた癌性疼痛の強さの評価方法
US20020165188A1 (en) 1999-10-14 2002-11-07 Meenhard Herlyn Methods for inhibition of tumorigenic properties of melanoma cells
US20030129677A1 (en) 2000-05-12 2003-07-10 Martens Mark G. Diagnostic method for screening complement regulatory protein levels
WO2001088537A1 (en) 2000-05-12 2001-11-22 Martens Mark G Diagnostic method for screening complement regulatory protein levels
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
CA2416633C (en) 2000-08-04 2013-04-30 Chiron Corporation Enhanced replication of hcv rna
EP1184458A1 (en) 2000-08-28 2002-03-06 U-BISys B.V. Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof
US20020115065A1 (en) 2000-08-28 2002-08-22 Ton Logtenberg Differentially expressed epitopes and uses thereof
US20030119080A1 (en) 2001-10-15 2003-06-26 Mangano Joseph A. Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
US7148038B2 (en) 2001-10-16 2006-12-12 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
US7771951B2 (en) 2001-12-03 2010-08-10 Amgen Fremont Inc. Antibody categorization based on binding characteristics
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
CN100516876C (zh) 2002-11-21 2009-07-22 惠氏公司 用于诊断肾细胞癌(rcc)和其他实体瘤的方法
US7534427B2 (en) * 2002-12-31 2009-05-19 Immunomedics, Inc. Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
US20060281136A1 (en) 2003-05-20 2006-12-14 Shinichi Nishikawa Preparation of endodermal stem cells
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
GB0406215D0 (en) 2004-03-19 2004-04-21 Procure Therapeutics Ltd Prostate stem cell
WO2005102456A1 (en) 2004-03-27 2005-11-03 The Arizona Board Of Regents On Behalf Of The University Of Arizona Composition and method for cancer treatment
WO2006051405A2 (en) 2004-11-12 2006-05-18 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
CN1940062B (zh) 2005-09-28 2010-04-28 上海市肿瘤研究所 一种肝癌干细胞及其分离方法和用途
CA2628255C (en) 2005-10-31 2016-04-19 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20070123448A1 (en) 2005-11-23 2007-05-31 The Hospital For Sick Children Novel chemical entities affecting neuroblastoma tumor-initiating cells
US20070248628A1 (en) 2005-12-06 2007-10-25 Keller Lorraine H Immunogens in cancer stem cells
US7622267B2 (en) 2006-05-30 2009-11-24 Van Andel Research Institute Low-density lipoprotein receptor 6 (LRP6) as a mammary stem cell marker and related methods
WO2007145901A1 (en) 2006-06-06 2007-12-21 University Of Tennessee Research Foundation Compositions enriched in neoplastic stem cells and methods comprising same
JP5382692B2 (ja) * 2006-07-10 2014-01-08 学校法人藤田学園 抗体の分類法、抗原の同定法、抗体又は抗体セットの取得法、抗体パネルの作成法、並びに抗体又は抗体セット及びその用途
EP2041574B1 (en) 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof
WO2009045201A1 (en) 2006-08-02 2009-04-09 Biogen Idec Ma Inc. Cancer stem cells
US20080118518A1 (en) 2006-09-07 2008-05-22 Cirrito Thomas P Cancer stem cell-targeted cancer therapy
CA2698597A1 (en) 2006-09-07 2008-03-13 Stemline Therapeutics, Inc. Monitoring cancer stem cells
EP2076587A4 (en) 2006-09-11 2009-12-09 Univ Florida ISOLATION, EXPANSION AND USE OF TUMOR STAMMING CELLS
AU2009233925B2 (en) 2006-12-05 2014-03-13 Ibc Pharmaceuticals, Inc. Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
US7781179B2 (en) 2006-12-07 2010-08-24 The Board Of Trustees Of The Leland Stanford Junior University Identification and isolation of transitional cell carcinoma stem cells
CA2675521C (en) 2007-01-22 2016-04-26 Raven Biotechnologies Human cancer stem cells
WO2008092002A2 (en) 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
WO2008149803A1 (ja) 2007-06-06 2008-12-11 The University Of Tokyo 表面抗原マーカーを用いた急性リンパ性白血病における癌幹細胞の分離同定方法
US9289492B2 (en) 2007-07-17 2016-03-22 The General Hospital Corporation Collecting ovarian cancer stem cells from ovarian cancer cells
JP5715817B2 (ja) 2007-07-19 2015-05-13 ビオメリューＢｉｏｍｅｒｉｅｕｘ 結腸直腸癌のインビトロ診断のための肝臓脂肪酸結合タンパク質、ｃｅａおよびｃａ１９−９のアッセイのための方法
US8168586B1 (en) 2007-11-21 2012-05-01 Celera Corporation Cancer targets and uses thereof
WO2009070767A2 (en) 2007-11-28 2009-06-04 Whitehead Institute For Biomedical Research Systemic instigation systems to study tumor growth or metastasis
EP2274617A4 (en) 2008-04-10 2011-11-09 Massachusetts Inst Technology METHOD OF DETECTING AND USING MEDIUM-TREATMENT AID ON CANCER STEM CELLS
WO2009139419A1 (ja) 2008-05-14 2009-11-19 公立大学法人横浜市立大学 ヒト肝幹細胞、その調製方法、分化誘導方法及び利用方法
US8197809B2 (en) 2008-06-25 2012-06-12 Korea Research Institute Of Bioscience And Biotechnology CD9-specific human antibodies
US20110313229A1 (en) 2008-07-24 2011-12-22 Kiminobu Sugaya Therapy Targeting Cancer Stem Cells
WO2010037134A2 (en) 2008-09-29 2010-04-01 Stemlifeline, Inc. Multi-stage stem cell carcinogenesis
AU2010206843B2 (en) 2009-01-20 2015-01-29 The Board Of Trustees Of The Leland Stanford Junior University Single cell gene expression for diagnosis, prognosis and identification of drug targets
US20110020221A1 (en) 2009-04-09 2011-01-27 The Johns Hopkins University Cancer stem cell expression patterns and compounds to target cancer stem cells
WO2011057034A2 (en) 2009-11-05 2011-05-12 Sloan Kettering Institute For Cancer Research Catenae: serosal cancer stem cells
EP2517555A4 (en) 2009-12-25 2014-09-24 Chugai Pharmaceutical Co Ltd SEARCHING AND SCREENING METHOD FOR A TARGET MOLECULE OF A CANCER WITH A NON-MENTAL ANIMAL MODEL WITH A NO-CANCER LINE OF TRANSPLANTED LINE
EP2347769A1 (en) 2010-01-20 2011-07-27 Glycotope GmbH Cancer stem cell markers and uses thereof
SG10201506782XA (en) * 2010-08-27 2015-10-29 Stem Centrx Inc Notum protein modulators and methods of use
US20130061340A1 (en) 2011-09-02 2013-03-07 Stem Centrx, Inc. Identification and Enrichment of Cell Subpopulations
WO2013119964A2 (en) 2012-02-08 2013-08-15 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
EP2689787A1 (en) 2010-09-03 2014-01-29 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US20130061342A1 (en) 2011-09-02 2013-03-07 Stem Centrx, Inc. Identification and Enrichment of Cell Subpopulations
WO2012044992A2 (en) 2010-09-30 2012-04-05 Agency For Science, Technology And Research (A*Star) Methods and reagents for detection and treatment of esophageal metaplasia
PL2621955T3 (pl) 2010-10-01 2018-07-31 National Research Council Of Canada Przeciwciała anty-CEACAM6 i ich zastosowania
GB201016852D0 (en) 2010-10-07 2010-11-17 Univ York Cell differentiation
SA112330278B1 (ar) 2011-02-18 2015-10-09 ستيم سينتركس، انك. مواد ضابطة جديدة وطرق للاستخدام
SG11201601424PA (en) 2013-08-28 2016-03-30 Stemcentrx Inc Site-specific antibody conjugation methods and compositions
EP3209334A2 (en) 2014-10-20 2017-08-30 Igenica Biotherapeutics, Inc. Novel antibody-drug conjugates and related compounds, compositions, and methods of use

Similar Documents

Publication Publication Date Title
JP2013539966A5 (https=)
Duo et al. Aggregation-induced emission luminogen: role in biopsy for precision medicine
Davidson et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles
Peterson et al. Integrated systems for exosome investigation
JP6240504B2 (ja) 細胞亜集団の同定及び濃縮
JP2023016981A (ja) 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
CN104178454B (zh) 一种循环肿瘤细胞的富集、分析方法
Lombardo et al. Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models
JP2021036915A (ja) ダイナミックｂｈ３プロファイリングを使用する毒性を評価するための組成物および方法
JP2016533752A (ja) オリゴヌクレオチドプローブおよびその使用
JP2009539097A5 (https=)
KR20150090072A (ko) 압타머 및 이의 용도
WO2013119964A2 (en) Identification and enrichment of cell subpopulations
KR20100101109A (ko) 혈액 내 순환 흑색종 세포의 자동화된 계산 및 특징화
Umelo et al. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies
Peng et al. DNA-programmed orientation-ordered multivalent microfluidic interface for liquid biopsy
Li et al. Tetrahedral framework nucleic acids linked CRISPR/Cas13a signal amplification system for rare tumor cell detection
Qi et al. Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer
Duan et al. Discovery and optimization of an aptamer and its sensing ability to amantadine based on SERS via binary metal nanoparticles
JP2012531612A5 (https=)
Yu et al. In situ analysis for protein corona: From morphology, composition, structure to dynamic process
Dong et al. Precise selection of aptamers targeting PD-L1 positive small extracellular vesicles on magnetic chips
Lee et al. Immunostaining extracellular vesicles based on an aqueous two-phase system: For analysis of tetraspanins
Ferguson et al. Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance
KR20130060009A (ko) 표적 물질 검출 및 분리 장치, 및 이를 이용한 표적 물질 검출 및 분리 방법